-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
May 13, 2014 - responses to the comments are posted for
public viewing on the EHC Program Web site approximately 3 months … Peer
Reviewer
#2
ES ES-10 last paragraph: The authors conjecture that the impact of nalmefene
was … The trial found no difference between
groups for the primary outcome of abstinence over
12 months.” … Also
several of the acamprosate studies were conducted for 6 to 12 months. … Using the intent
to treat the effect disappeared after three months.
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - Peer Reviewer
#6
Executive
Summary
(1) on page 13 of 255 (first page of the Executive Summary, last … The findings are not consistent with administrative claims data in the last
10 years which show ongoing … At last, a clear statement about need for improved functioning. … p.144, last paragraph sentences adjusted to
reflect issues raised. … p p.147, last paragraph, emphasis now reflects
ongoing increases in medication use rather
than rates
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - Noninvasive Nonpharmacologic Treatments for Chronic Pain
9
BACKGROUND
Chronic pain:
Pain lasting ≥ 3 months … Pacific Northwest Evidence-based Practice Center
Summary of Evidence on Benefits
Short-Term: 1 to <6 Months … Pacific Northwest Evidence-based Practice Center
Summary of Evidence on Harms
Short-Term: 1 to <6 Months … Change in Overall Function: Comparable THC to CBD Ratio Versus Placebo
Short-Term: 1 to <6 Months … Placebo
Short-term: 1 to <6 months
Living Review
28
Entering third year since initial review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
November 07, 2023 - the authors’ responses to the comments are posted
for public viewing on the website approximately 3 months … Public Comment
#3 (APA)
ES ES-1 last pg Change "update" to "updated" Revised. … Public Comment
#3 (APA)
Discussion p. 59 Applicability pg 3 last sentence. … The
last two sentences of this 1st pg are a bit unclear. … A20 last of bullet points.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_executive.pdf
February 01, 2014 - million women in the United States
smoke.3 Nationally, 23 percent of women
report smoking in the 3 months … before
pregnancy, while 13 percent report smoking
in the last 3 months of pregnancy. … PICOTS
PICOTS Criteria
Population • Pregnant or postpartum (≤6 months post-birth) women who smoke or … We included studies
of pregnant or postpartum (within 6 months of birth)
women who currently smoked … aDemonstrated effectiveness at end of pregnancy but was no longer significant at 6 months postpartum.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
August 01, 2015 - Cancer cells will keep dying for weeks or months after
radiation therapy ends. … How long might they last?
� When should I tell you about any side effects?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication … prior to recruitment, were not pregnant, and were willing to return at 6 and 12 months. … The mean followup in those completing less than 12 months was 9.7 months (IQR 8.7 to 10.8) Yes Yes Yes … Weng): Yes
Last academic author (J. Fan): No
Corresponding author (J. … Last author is university employed and did not have any declared conflicts of interest.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication … prior to recruitment, were not pregnant, and were willing to return at 6 and 12 months. … The mean followup in those completing less than 12 months was 9.7 months (IQR 8.7 to 10.8) Yes Yes Yes … Weng): Yes
Last academic author (J. Fan): No
Corresponding author (J. … Last author is university employed and did not have any declared conflicts of interest.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - depending on expert comments received on interventions issued for
comment during the preceding 6 months … This test indicates the
patient’s average blood sugar level for the previous 2 or 3 months, and an … HbA1c reductions of 4% or greater and 25% of patients achieving an HbA1c level of less
than 7% at the last … “Discontinuations for nausea were in the low single
digits over the full 12 months of treatment. … The longest implant prior to Iluvien was a dexamethasone implant that lasted about 4
months.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-one-year-disposition-comments.pdf
June 02, 2023 - the authors’ responses to the comments are posted
for public viewing on the website approximately 3 months … This guidance is
cited in the last section of
the Methods. … included in the
systematic review:
• Interrante 2022 –
This article was
published after the
date of last … • Wouk 2022 – This
article was published
after the date of last
search at the time of
the draft
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
January 01, 2023 - Background and Objectives for the Systematic Review
Despite fluctuating trends in mortality rates in the last … Furthermore, the adequate intake (AI) of
carbohydrates for infants (age 0-12 months) was determined … based on the average intake
consumed in human milk and supplementary foods.15 AI for infants under 6 months … of age is
60 g/d of carbohydrates, which increases to 95 g/d between 6 and 12 months. … The disposition of
comments for systematic reviews and technical briefs will be published 3 months after
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
December 14, 2017 - the authors’ responses to the comments are posted for
public viewing on the Web site approximately 3 months … Of note,
our first patient done in 2010 used to be on prednisone 4 to 6
times a year. 2010 was her last … Clinical benefit was detectable at
3 months after BT and persisted until 12 months. … after therapy
and can last for at least 5 years, after
which the duration of effect is unknown.” … Differences in baseline
demographics and clinical correlates in the 12 months prior to
BT indicate:
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
December 03, 2019 - the authors’ responses to the comments are posted for
public viewing on the Web site approximately 3 months … Seraphine Lambert References Most of the references appeared recent (within the last 5 to
7 years)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - same period.19
Chemoembolization drugs and embolic mixtures have
also changed a great deal in the last … The mean TTP was longer in the DEB group (10.6 ±
2.4 months) than the TAE group (9.1 ± 2.3 months; p … TACE vs. 13.1 months after DEB). … with TACE and 10.4 months (range: 1.0 to 42.7
months) in patients treated with RFA (p = 0.95). … progression-free survival, measured from the date of first
study treatment to the date of death or last
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - details for these
patients
OS Of the 12 patients
that received stem
cell transplant 7
were alive at last … This
compared with 74
patients who did
not receive stem
cell transplant with
27 alive at last
follow … at
last follow up (104
months). … of 6 months. … The PFS was 56% ± 4
with a median follow up
of 92 months for
survivors (6-168
months).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
January 01, 2024 - thyroid disease, or a psychiatric disorder); taking any medications or supplements in the previous 3 months … antibiotics or any other medical treatment influencing gut transit or intestinal flora for at least 3 months … ; antibiotics within 6 months; constipation; diarrhoea; other gastrointestinal complaint 3 wk 3 wk 5/ … affecting gut motility, eating disorders; pregnant/lactating women; and abdominal ionising radiation in last … prior to screening and consumption of pre- or probiotics or any fibre supplement during the last month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
January 01, 2024 - thyroid disease, or a psychiatric disorder); taking any medications or supplements in the previous 3 months … ; antibiotics within 6 months; constipation; diarrhoea; other gastrointestinal complaint 3 wk 3 wk 5/ … anti-inflammatory drug and/or corticosteroid intake, or laxative or antibiotic intake within
three months … affecting gut motility, eating disorders; pregnant/lactating women; and abdominal ionising radiation in last … prior to screening and consumption of pre- or probiotics or any fibre supplement during the last month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
June 05, 2013 - responses to the comments are posted for
public viewing on the EHC Program Web site approximately 3 months … Fasting blood glucose was
lower in the surgical patients at 24 months compared to the
medical group … Peer Reviewer 2 Results p. 20, 2nd paragraph, discrepancy:
• “At 24 months postoperative, both groups … (last 4
sentences of paragraph). … Peer Reviewer 2 Results p. 30, last paragraph: some readers might interpret the following
passage as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
May 27, 2014 - Unlike most other recent reviews, this review
focuses on short-term outcomes (less than 6
months). … Section Comment Response
61 Peer Reviewer
7
Abstract Line 27: The letter “h” is missing from the last … we
are referring to future research needs.
175 TEP Reviewer 4 Results In Table 4, please change last … corrected.
209 Peer Reviewer
7
Results Table 4: I believe there is an error in the heading of the last … , or 12 months, or 2
years?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
April 21, 2015 - of bother created by the LUTS.5
Trends in medical management of LUTS/BPH have progressed over the last … Our review will comprehensively assess newer medications for
LUTS/BPH newly used in the last 10 years … serious medication side effects
Timing
Short term outcomes - treatment duration between 1 and 6 months … • Sustained efficacy/comparative effectiveness: over 6 months
Publication type Published in peer … The disposition of comments for systematic
reviews and technical briefs will be published three months